CALL - SPRINTER OPEN END - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000VV72SY8

Market Closed - Börse Stuttgart 09:03:30 05/07/2024 pm IST
16.72 EUR +0.72% Intraday chart for CALL - SPRINTER OPEN END - FRESENIUS MEDICAL CARE
Current month+0.66%
1 month-16.94%
Date Price Change
05/24/05 16.72 +0.72%
04/24/04 16.6 +1.59%
03/24/03 16.34 +0.12%
02/24/02 16.32 -1.81%
01/24/01 16.62 +0.06%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 09:03 pm IST

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VV72SY
ISINDE000VV72SY8
Date issued 10/10/2022
Strike 19.37
Maturity Unlimited
Parity 1 : 1
Emission price 7.78
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 30.61
Lowest since issue 7.06

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
36.16 EUR
Average target price
39.97 EUR
Spread / Average Target
+10.55%
Consensus